Skip to main content
Industry News
Study looks at efficacy of i-Port Advance system in T1D
4/12/2021

Patients with type 1 diabetes who used the i-Port Advance injection port for 12 weeks not only increased their satisfaction levels, but also experienced improvements in A1C levels, fasting blood glucose and postprandial glucose, according to a study in Diabetes & Metabolic Syndrome: Clinical Research & Reviews. The number of hypoglycemic episodes also significantly decreased with use of the i-Port Advance system.

Full Story: